Effects of penetration enhancers on the in-vitro percutaneous absorption of progesterone

Journal of Pharmacy and Pharmacology

Volumn 49, Issue 10, 1997, Pages 955-959

  Valenta, Claudia ^a   Wedenig, Sabine ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOMER; LAUROCAPRAM; MACROGOL; PROGESTERONE; PROPYLENE GLYCOL; UREA;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG PENETRATION; FEMALE; GEL; NONHUMAN; OINTMENT; PREMENSTRUAL SYNDROME; RAT; SKIN; SKIN ABSORPTION; SWINE;

EID: 0030682120     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.2042-7158.1997.tb06023.x     Document Type: Article

References (32)

1. Artini, P. G., Volpe, A., Angioni, S., Galassi, M. C., Battaglia, C., Genazzani, A. R. (1995) A comparative, randomized study of three different progesterone supports of the luteal phase following IVF/ET program. J. Endocrinol. Invest. 18: 51-56
2. Barry, B. W. (1987) Mode of action of penetration enhancers in human skin. J. Contr. Rel. 6: 85-97
3. Barry, B. W., Bennett, S. L. (1987) Effect of penetration enhancers on the permeation of mannitol, hydrocortisone and progesterone through human skin. J. Pharm. Pharmacol. 39: 535-546
4. 2 transport through human skin in vitro. Int. J. Pharm. 53: 13-24
5. Chowhan, Z. T., Pritchard, R. (1978) Effect of surfactants on percutaneous absorption of naproxen I: comparison of rabbit, rat and human excized skin. J. Pharm. Sci. 67: 1272-1274
6. Cleary, G. W. (1984) Transdermal controlled-release systems. In: Niedner, R., Ziegenmeyer, J. (eds) Dermatika. Wissenschaftliche Verlagsgesellschaft, Stuttgart, pp 265-266
7. Dennerstein, L., Spencer-Gardner, C., Gotts, G., Brown, J. B., Smith, M. A., Burrows, G. D. (1985) Progesterone and the premenstrual yndrome: a double-blind cross-over trial. Br. Med. J. 290: 1617-1621
8. Diez-Sales, O., Watkinson, A. C., Herraezdominguez, M., Javaloyes, C., Hadgraft, J. (1996) A mechanistic investigation of the in vitro human skin permeation enhancing effect of Azone. Int. J. Pharm. 129: 33-40
9. Hadgraft, J. (1996) Recent developments in topical and transdermal delivery. Eur. J. Drug Metab. Pharmacokinet. 21: 165-173
10. Harrison, J. E., Watkinson, A. C., Green, D. M., Hadgraft, J., Brain, K. (1996) The relative effect of Azone and transcutol on permeant diffusivity and solubility in human stratum corneum. Pharm. Res. 13: 542-546
11. Huth, S., Neubert, R., Boltze, L., Buge, A. (1996) Experimental determination and mathematical modelling of propylene glycol transport from semisolid vehicles. Chem. Pharm. Bull. 44: 1263-1266
12. Johnson, M. E., Blankschtein, D., Langer, R. (1995) Permeation of steroids through human skin. J. Pharm. Sci. 84: 1144-1146
13. Knepp, V. M., Hinz, R. S., Szoka, F. C., Guy, R. H. (1988) Controlled drug release from novel liposomal delivery system. Part 1. Investigation of transdermal potential. J. Contr. Rel. 5: 211-221
14. Knutson, K., Harrison, D. J., Pershing, L. K., Goates, C. Y. (1993) Transdermal absorption of steroids. J. Contr. Rel. 24: 95-108
15. Lewis, L. L., Greenblatt, E. M., Rittenhouse, C. A., Veldhuis, J. D., Jaffe, R. B. (1995) Pulsatile release patterns of luteinizing hormone and progesterone in relation to symptom onset in women with premenstrual syndrome. Fertil. Steril. 64: 88-292
16. Norman, T. R., Morse, C. A., Dennerstein, L. (1991) Comparative bioavailability of orally and vaginally administered progesterone. Fertil. Steril. 56: 1034-1039
17. Pershing, L. K., Lambert, L. D., Knutson, K. (1990) Mechanism of ethanol-enhanced estradiol permeation across human skin in vivo. Pharm. Res. 7: 170-175
18. Phillips, C. A., Michniak, B. B. (1995a) Topical application of Azone to hairless mouse skin - a histopathological study. Int. J. Pharm. 125: 63-71
19. Phillips, C. A., Michniak, B. B. (1995b) Transdermal delivery of drugs with differing lipophilicities using Azone analogs as dermal penetration enhancers. J. Pharm. Sci. 84: 1427-1433
20. Potts, R. O., Golden, G. M., Francoeur, M. L., Mak, V. H. W., Guy, R. H. (1991) Mechanism and enhancement of solute transport across the stratum corneum. J. Contr. Rel. 15: 249-260
21. Price, J. H., Ismail, H., Gorwill, R. H., Sarda, I. R. (1983) Effect of the suppository base on progesterone delivery from the vagina. Fertil. Steril. 39: 490-493
22. Safwat, S. M., Tous, S. S., Mohamed, M. M. (1991) Preformulation study of progesterone from dosage form design, release characteristics and bioavailability of progesterone suppositories. Pharm. Ind. 53: 1144-1150
23. Sitruk-Ware, R., Bricaire, C., Lignieres, B., Yaneva, H., Mauvais-Jarvis, P. (1987) Oral micronized progesterone, bioavailability pharmacokinetics, pharmacological and therapeutic implications - a review. Contraception 36: 373-402
24. Smith, S., Schiff, I. (1989) The premenstrual syndrome - diagnosis and management. Fertil. Steril. 52: 527-543
25. Stoughton, R. B., McClure, W. O. (1983) Azone: a new non-toxic enhancer of cutaneous penetration. Drug Dev. Ind. Pharm. 9: 725-744
26. Szolarplatzer, C., Patil, S., Maibach, H. I. (1996) Effect of topical laurocapram (Azone) on the in vitro percutaneous permeation of sodium lauryl sulfate using human skin. Acta Dermato-Venerologica. 76: 182-185
27. Toddywala, R. D., Ulman, K., Walters, P., Chien, Y. W. (1991) Effect of physicochemical properties of adhesive on the release, skin permeation and adhesiveness of adhesive-type transdermal drug delivery systems (a-TDD) containing silicone-based pressure-ensitive adhesives. Int. J. Pharm. 76: 77-89
28. Valenta, C., Janout, H. (1994) Corticosteroid analysis by HPLC with increased sensitivity by use of precolumn concentration. J. Liq. Chromatogr. 17: 1141-1146
29. Valenta, C., Schmatzberger-Wagerer, M. (1995) Stability testing of progesterone hydrogels. Pharmazie 50: 69-70
30. Wang, M. D., Seippel, L., Purdy, R. H., Backstrom, T. (1996) Relationship between symptom severity and steroid variation in women with premenstrual syndrome. J. Clin. Endocrinol. Metab. 81: 1076-1082
31. Wester, R. C., Maibach, H. S. (1985) Animal models for percutaneous absorption. In: Maibach, H. J., Lowe, N. (eds) Models in Dermatology. Vol. 2, Karger, Basel, pp 159-169
32. Wotton, P. K., Mollgaard, B., Hadgraft, J., Hoelgaard, A. (1985) Effect of Azone on the cutaneous permeation of metronidazole and propylene glycol. Int. J. Pharm. 24: 19-26